BENCH & PHANTOM
Signal characterization and component iteration
Bench and phantom testing has been used to evaluate signal acquisition, device geometry, material behavior, imaging depth, and repeatability across successive prototypes.
PRECLINICAL EVIDENCE
A development program built around iterative feasibility testing.
SoundPass is using bench, cadaveric, and animal work to refine EchoVent and plan future verification, validation, and regulatory activities.
CADAVERIC FEASIBILITY
Extensive testing across multiple cadaveric models
Across multiple cadaveric models representative of anticipated live human anatomy, the team reports greater than 90% first-pass accuracy. These findings are preclinical and do not demonstrate performance in patients.
ANIMAL FEASIBILITY
In-vivo large-animal feasibility completed
The team reports greater than 95% first-pass accuracy in an in-vivo large-animal model. The study also assessed technical feasibility in a live model, workflow timing, and device performance under in-vivo conditions. These findings remain preclinical and have not been clinically validated.
VOICE OF CUSTOMER
150+ neurosurgeons across 40+ institutions
Structured conversations have informed user requirements, workflow priorities, interface design, and potential adoption considerations. Market research is not clinical evidence.
How to interpret these findings
All results described here are preclinical.
Cadaveric and animal findings may not predict performance in humans.
Device design, software, and intended use may change during development.
Internal findings described here may not yet be peer-reviewed or independently replicated.
CONNECT WITH SOUNDPASS
Research, clinical, and strategic collaboration
We welcome inquiries from clinicians, researchers, prospective partners, and investors interested in the SoundPass mission.